Skip to main content
N

NanoSphere Health Sciences Inc. — Investor Relations & Filings

Ticker · NSHS LEI · 967600TUDEI9B87J8S25 CSE Professional, scientific and technical activities
Open in API
Filings indexed 82 across all filing types
Latest filing 2025-08-30 Regulatory Filings
Country CA Canada
Listing CSE NSHS

About NanoSphere Health Sciences Inc.

NanoSphere Health Sciences Inc. is a nano-biotechnology company specializing in the development and commercialization of advanced drug delivery systems. The company's core technology is the proprietary NanoSphere Delivery System platform, which is focused on providing next-generation delivery of biologically active compounds, nutritive elements, and medications. This platform addresses various markets, including supplements, cannabis, pharmaceuticals, over-the-counter products (OTCs), and cosmetics. NanoSphere operates primarily through licensing and joint venture arrangements to facilitate the distribution and application of its technology.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a NI 52-109 Form 52-109FV2 certificate by an independent director certifying the interim financial report and interim MD&A for the period ended June 30, 2025. It is not the interim report itself nor an earnings release, but a regulatory compliance certificate. There is no specific category for such certification forms, so it falls under the fallback “Regulatory Filings” (RNS).
2025-08-30 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a 'Form 52-109FV2 Certification of Interim Filings', which is an officer certification/attestation document. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference other reports like interim filings. The document does not contain the actual financial statements or substantive financial data required for an Interim Report (IR) classification. H1 2025
2025-08-30 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “Management’s Discussion & Analysis” (Form 51-102F1) for the six months ended June 30, 2025, describing financial results, operations, liquidity, accounting policies, and risks. This is the MD&A section, i.e., management’s detailed explanation of financial performance and outlook, which maps to the Management Reports category (Code: MDA).
2025-08-30 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS' for the six months ended June 30, 2025. It contains comprehensive financial statements (Statement of Financial Position, Statement of Income/Loss, Statement of Cash Flows, Statement of Changes in Shareholders' Deficiency) and detailed notes to the financial statements. It is not an announcement or a summary, but the actual interim financial report itself, fitting the definition of an Interim/Quarterly Report (IR). H2 2025
2025-08-30 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a certification letter (Form 52-109FV2) by a venture issuer’s certifying officer attesting to the interim filings (interim financial report and interim MD&A). It does not itself contain the full interim report content (financial statements or MD&A) but is a regulatory filing component. It is not an announcement of report publication nor one of the specific categories (audit report, earnings release, M&A, etc.). Therefore it falls into the general Regulatory Filings fallback category (RNS).
2025-05-30 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a certification form (Form 52-109FV2) by the CFO certifying the interim financial report and MD&A for the period ended March 31, 2025. It is not the interim report itself, nor an announcement of dividend, earnings release, or management change, but a regulatory compliance filing under Canadian securities rules. This falls under the generic “Regulatory Filings” category.
2025-05-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.